OrbusNeich to trial Genous follow-up
This article was originally published in Clinica
Executive Summary
OrbusNeich has kicked off a randomised clinical trial of its Combo stent. The sirolimus-eluting device will be up against Boston Scientific's paclitaxel-eluting Taxus Liberté stent in the 180-patient study.